-
Mashup Score: 9
Selection of donors based on HLA B-leader and peptide binding motifs, the role of NK cells, and other HLA/non-HLA factors in donor selection.
Source: tandem.confex.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4ASTCT Spotlight Session: ASTCT/FDA Joint Session - 3 month(s) ago
Sign In My TimeCST …
Source: tandem.confex.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Tandem Meetings Late Breaking Abstracts - 3 month(s) ago
Sign In My TimeCST …
Source: tandem.confex.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 52024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - 3 month(s) ago
Welcome to the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR…please wait while the program loads.
Source: tandem.confex.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7Plenary [ASTCT]: The Future of Cellular and Gene Therapy - 3 month(s) ago
The session will review new approaches to the treatment of hematologic and solid tumor malignancies, including the use of small-interfering RNA, engineered TCRs and the combination of CART and mRNA vaccines.
Source: tandem.confex.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Real World Outcomes for AYA Patients with Relapsed/Refractory B-Cell ALL Receiving CD19-Directed CAR T-Cell Therapy - 3 month(s) ago
Introduction: Tisagenlecleucel (tisa-cel) and brexucabtagene autoleucel (brexu-…
Source: tandem.confex.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9Donor Search and Selection Strategy to Facilitate Comparable Transplant Rates across Donor Search Prognosis Groups: A Report from the BMT CTN 1702 Trial - 3 month(s) ago
Historically, many transplant (HCT)-eligible patients have not reached HCT due …
Source: tandem.confex.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World Analysis - 3 month(s) ago
Ibrutinib has been studied in steroid-refractory chronic graft vs. host disease…
Source: tandem.confex.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 10Daily Welcome & Awards: Saturday - 3 month(s) ago
Sign In My TimeCST …
Source: tandem.confex.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Outcomes of Haploidentical Stem Cell Transplant Recipients with HHV-6 Reactivation Receiving Antiviral Therapy - 3 month(s) ago
Background Human herpesvirus 6 (HHV-6) frequently reactivates following allogen…
Source: tandem.confex.comCategories: General Medicine News, Onc News and JournalsTweet
This afternoon's plenary, Selecting an Ideal HLA-Mismatched Donor: Old Art, New Science, chaired by Dr. Rohtesh Mehta, will begin at 4:15 PM CT: https://t.co/KQ5nkoU2qJ #Tandem24 https://t.co/6ndg3bYAzW